Skip to main content

Acerus Pharmaceuticals Corp(ASP-T)
TSX

Today's Change
Real-Time Last Update
Volume
Day Low0.3600
Day High0.3600
Open:0.3600
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

Download Premium PDFRefinitiv. Trademark. Data is Just the Beginning.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

Download Premium PDFStockCalc

Press & news

Latest News

More Stories
Acerus Pharmaceuticals: Bottom 25 Performing Stocks Year-to-Date on TSX (ASP)
The Globe and Mail - Thu Mar 2, 10:20AM CST
The Globe and Mail
Thu Mar 2, 10:20AM CST
Acerus Pharmaceuticals is among the group of bottom performing stocks year-to-date on the Toronto Stock Exchange. This means each stock on this list has seen its share price decrease at a faster rate than the rest of the market so far this year.
Acerus Pharmaceuticals: Stocks trading at Less Than Cash Value on TSX (ASP)
The Globe and Mail - Sun Feb 26, 10:10AM CST
The Globe and Mail
Sun Feb 26, 10:10AM CST
Acerus Pharmaceuticals is among the group of Toronto Stock Exchange companies currently trading at less than cash value. This means companies whose current share price is less than the cash per share on their balance sheet or stocks with more cash...
Acerus Pharmaceuticals: Top 10 Undervalued Healthcare Sector Stocks on TSX (ASP)
The Globe and Mail - Tue Feb 7, 10:01AM CST
The Globe and Mail
Tue Feb 7, 10:01AM CST
Acerus Pharmaceuticals is now ranked among the top 10 undervalued stocks in the Healthcare sector on the Toronto Stock Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the...

Latest Articles

Most actively traded companies on the TSX
Most actively traded companies on the TSX
Most actively traded companies on the TSX
Most actively traded companies on the TSX
Multiple insider buying at Acerus Pharmaceuticals
Most actively traded companies on the TSX
Most actively traded companies on the TSX
Most actively traded companies on the TSX
Eugene Melnyk files claim accusing CEO, chairman of ‘destroying’ Acerus
Eugene Melnyk’s battle over sinking upstart Acerus Pharmaceuticals
Ottawa Senators owner Eugene Melnyk files notice that he's suing Acerus Pharma
Eugene Melnyk suing Acerus for ‘gross mismanagement’

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2023 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.